Total Payments
$14,045
2024 Payments
$3,016
Companies
53
Transactions
775
Medicare Patients
5,736
Medicare Billing
$878,970
Payment Breakdown by Category
Food & Beverage$13,950 (99.3%)
Education$94.48 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,950 | 767 | 99.3% |
| Education | $94.48 | 8 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,003 | 117 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,268 | 127 | $0 (2024) |
| Novo Nordisk Inc | $1,703 | 140 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $842.43 | 39 | $0 (2024) |
| Lilly USA, LLC | $742.13 | 58 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $695.13 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $483.53 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $422.39 | 30 | $0 (2022) |
| ABBVIE INC. | $402.62 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $390.30 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,016 | 95 | AstraZeneca Pharmaceuticals LP ($983.25) |
| 2023 | $2,551 | 113 | GlaxoSmithKline, LLC. ($632.64) |
| 2022 | $1,724 | 103 | Novo Nordisk Inc ($387.17) |
| 2021 | $1,787 | 91 | Novo Nordisk Inc ($361.73) |
| 2020 | $1,241 | 97 | GlaxoSmithKline, LLC. ($319.54) |
| 2019 | $1,699 | 137 | AstraZeneca Pharmaceuticals LP ($303.88) |
| 2018 | $885.76 | 70 | AstraZeneca Pharmaceuticals LP ($285.34) |
| 2017 | $1,142 | 69 | AstraZeneca Pharmaceuticals LP ($276.10) |
All Payment Transactions
775 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Hyperkalemia | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Hyperkalemia | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $96.59 | General |
| Category: GI | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: DIABETES | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Hyperkalemia | ||||||
| 09/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Obesity | ||||||
| 08/30/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,602 | 3,779 | $551,065 | $225,504 |
| 2022 | 19 | 1,448 | 3,832 | $567,015 | $236,673 |
| 2021 | 19 | 1,316 | 3,493 | $529,985 | $219,260 |
| 2020 | 28 | 1,370 | 3,424 | $496,878 | $197,534 |
Total Patients
5,736
Total Services
14,528
Medicare Billing
$878,970
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 948 | $237,000 | $97,375 | 41.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 168 | 798 | $67,830 | $41,641 | 61.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 116 | 683 | $102,450 | $30,639 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 105 | 105 | $26,250 | $14,931 | 56.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 100 | 230 | $13,800 | $9,418 | 68.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 20 | $8,000 | $4,887 | 61.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 66 | 70 | $23,100 | $4,121 | 17.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 102 | 104 | $4,160 | $3,533 | 84.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $5,400 | $3,102 | 57.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 38 | $3,040 | $2,870 | 94.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $4,800 | $2,715 | 56.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 111 | 111 | $6,660 | $2,311 | 34.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 109 | 109 | $5,450 | $2,269 | 41.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 35 | 60 | $3,000 | $1,664 | 55.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 58 | 61 | $4,575 | $1,332 | 29.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 103 | 110 | $8,250 | $1,222 | 14.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 109 | 226 | $22,600 | $725.46 | 3.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 31 | $1,550 | $390.60 | 25.2% |
| 90471 | Administration of vaccine | Office | 2023 | 18 | 19 | $1,425 | $328.86 | 23.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 23 | $1,725 | $28.94 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 244 | 989 | $247,250 | $107,836 | 43.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 180 | 850 | $72,250 | $45,073 | 62.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 119 | 632 | $94,800 | $30,757 | 32.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 98 | 289 | $37,570 | $11,986 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 79 | 79 | $19,750 | $11,521 | 58.3% |
About Dr. Vikram Gupta, M.D
Dr. Vikram Gupta, M.D is a Family Medicine healthcare provider based in Clifton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750538609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Gupta, M.D has received a total of $14,045 in payments from pharmaceutical and medical device companies, with $3,016 received in 2024. These payments were reported across 775 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($13,950).
As a Medicare-enrolled provider, Gupta has provided services to 5,736 Medicare beneficiaries, totaling 14,528 services with total Medicare billing of $878,970. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties General Practice
- Location Clifton, NJ
- Active Since 08/22/2008
- Last Updated 10/02/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750538609
Products in Payments
- FARXIGA (Drug) $2,074
- TRELEGY ELLIPTA (Drug) $1,131
- JARDIANCE (Drug) $848.82
- Kerendia (Drug) $695.13
- Ozempic (Drug) $493.07
- Rybelsus (Drug) $468.96
- AREXVY (Drug) $380.74
- TRULICITY (Drug) $364.99
- ENTRESTO (Drug) $347.23
- BREZTRI (Drug) $319.68
- Linzess (Drug) $291.76
- XARELTO (Drug) $275.50
- LOKELMA (Drug) $270.17
- VERQUVO (Drug) $257.71
- Victoza (Drug) $251.01
- RYBELSUS (Drug) $245.65
- SOLIQUA 100/33 (Biological) $230.86
- Veltassa (Drug) $227.26
- Vascepa (Drug) $200.00
- Creon (Drug) $158.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clifton
Dr. Samir Khalil, Md, MD
Family Medicine — Payments: $40,270
Family Medicine $40,270
Anna Pudinak, M.d, M.D
Family Medicine — Payments: $19,524
Family Medicine $19,524
Dr. Cheng-An Mao, M.d, M.D
Family Medicine — Payments: $9,788
Family Medicine $9,788
Dr. Mukundha Maneyapanda, M.d, M.D
Family Medicine — Payments: $5,307
Family Medicine $5,307
Justin Squyres, Md, MD
Family Medicine — Payments: $3,413
Family Medicine $3,413
Jenny Chien, M.d, M.D
Family Medicine — Payments: $3,300
Family Medicine $3,300